Woody Sherman is the CEO of Psivant Therapeutics and an Adjunct Professor at the University of Massachusetts Amherst, with a background in physical chemistry and experience in roles such as Chief Computational Scientist and CSO at various biotech companies. Prior to their current positions, Woody founded MolySym, Inc., a technology company focused on chemistry education.
Current role